2026-01-26T12:58:04-07:00 2025-06-30 990 2024-07-01 251462312 MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION MAGE 4126418957 204 Craft Avenue Pittsburgh PA 15213 Michael Annichine CEO 4126418949 2026-01-16 1 2024 2025-03-06 01:10:19Z X Michael Annichine 204 Craft Avenue Pittsburgh PA 15213 192699361 0 X www.mageewomens.org X 1984 PA Magee-Womens Research Institute's mission is to advance scientific knowledge in the fields of reproductive biology and women's health. 25 23 0 114 0 0 68735058 57030726 331557 501991 7320946 6085896 -219200 -80736 76168361 63537877 37334864 30293363 0 0 21605796 20198577 300000 300000 2280116 16328985 14133848 75569645 64925788 598716 -1387911 101671185 95797947 36533171 32323533 65138014 63474414 X The mission of Magee-Womens Research Institute and Foundation is to advance scientific knowledge in the fields of reproductive biology and women's health; translate this knowledge into improved health for women and infants; train current and future scholars of reproductive sciences and women's health; and foster community investment and involvement in women's health. 0 0 57231637 30293363 535296 See Schedule O 0 0 0 57231637 1 1 0 0 0 0 0 0 0 1 1 1 0 0 1 0 1 0 0 0 1 1 0 1 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 89 0 1 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 X 25 23 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AR CA CO CT DC FL GA HI IL KS KY LA MA MD ME MI MN MO MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV WY X Timothy Bell Sr Director of Finance 4126418957 204 Craft Avenue Pittsburgh PA 15213 X Michael Annichine CEO 40 0 X X 590079 0 61105 Yoel Sadovsky Principal Investigator 40 0 X 552230 0 85255 Gerald Schatten Principal Investigator 40 0 X 404439 0 61796 Sharon Hillier Principal Investigator 40 0 X 369392 0 45857 Kyle Orwig Principal Investigator 40 0 X 340990 0 48030 Lisa Rohan Principal Investigator 40 0 X 281750 0 57691 Pamela Moalli Interim Executive Director/Principal Investigator 40 0 X X 236976 0 46979 Theresa Bone Vice Chair 2.5 0 X X 0 0 0 Robert Edwards Director 1 0 X 0 0 0 Joan Ellenbogen Director 1 0 X 0 0 0 Margaret Joy Director 1 0 X 0 0 0 William Pietragallo Director 1 0 X 0 0 0 W Scott Sanford Director 1 0 X 0 0 0 Richard Beigi Director 1 0 X 0 0 0 Tony Lacenere Director 1 0 X 0 0 0 Mary Richter Director 1 0 X 0 0 0 Fern Schwartz Director 1 0 X 0 0 0 Margaret Archinaco Director 1 0 X 0 0 0 Anantha Shekhar Director 1 0 X 0 0 0 David Spigelmyer Director 1 0 X 0 0 0 Margot Bingham Director 1 0 X 0 0 0 Carrie Coghill Director 1 0 X 0 0 0 Kelly R Gray Chair 2.5 0 X X 0 0 0 Jason Harrison Treasurer 2.5 0 X X 0 0 0 Susan McGalla Secretary 2.5 0 X X 0 0 0 Nicole Donnellan Director 1 0 X 0 0 0 Olivia Brinker Director 1 0 X 0 0 0 Sheila Escovedo Director 1 0 X 0 0 0 Deborah Murphy Director 1 0 X 0 0 0 Carli Siger Director 1 0 X 0 0 0 2775856 0 406713 65 0 1 1 Clark Hill PLC 1 Oxford Centre 301 Grant St Floor 14 Pittsburgh PA 15219 Legal 672044 Sparks & Honey LLC 220 East 42nd Street New york NY 10017 Strategic Planning 350000 Pitch Consulting LLC 245 Tech Rd Pittsburgh PA 15205 Event Organizer 296379 Turhow Consulting Group LLC 2892 Basford Road Frederick MD 21703 Business Consulting 159250 Blackbaud 65 Fairchild Street Charleston SC 29492 Software 156031 8 X 45731 0 229009 0 42648242 14107744 80107 57030726 Service fee revenue 541380 501991 501991 0 0 0 0 0 0 501991 1139986 0 0 1139986 0 0 0 0 0 0 0 0 33305 0 0 0 33305 0 33305 33305 0 0 133344879 0 128398969 0 4945910 0 4945910 0 0 4945910 648474 229009 762515 -114041 0 -114041 0 63537877 535296 0 5971855 26949164 26949164 0 0 3344199 3344199 0 0 685482 130025 555457 0 0 0 0 0 15684767 11600236 2856940 1227591 0 0 0 0 3828328 2806594 712792 308942 0 0 0 0 0 0 0 0 0 0 0 0 55549 0 55549 0 0 0 0 0 300000 300000 264041 0 264041 0 1097070 881335 -31370 247105 119548 0 5850 113698 315282 245969 28452 40861 436663 161687 134697 140279 0 0 0 0 2602496 2239691 301693 61112 1042480 597023 294051 151406 0 0 0 0 305289 220899 48150 36240 0 0 0 0 0 0 0 0 2038156 1988089 46789 3278 0 0 0 0 Lab equipment & maintenance 301155 301003 152 0 Medical research lab supplies 2949092 2925466 23626 0 Various lab testing and processing fees 2184259 2184222 37 0 Fundraising expenses included in Part VIII -762515 0 0 -762515 1185283 656035 117129 412119 64925788 57231637 5414035 2280116 4619531 5768860 14338852 11417210 334080 317715 650564 504346 60596725 34536282 27614468 26060443 54113690 51729373 101671185 95797947 4629666 4364074 5965375 3567763 538950 381116 21478378 20253478 3920802 3757102 36533171 32323533 X 5438720 5900617 59699294 57573797 65138014 63474414 101671185 95797947 -1387911 -275689 0 0 0 0 X 0 1 X 1 1 1 X 48929887 52285286 65287943 68735058 57030726 292268900 0 0 0 0 48929887 52285286 65287943 68735058 57030726 292268900 3514569 288754331 1532827 1765894 1272658 1257970 1173292 7002641 0 0 0 0 0 0 0 299271541 2883669 0.96486 0.95707 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 27408070 32044 2939317 0 1027391 0 29352040 25681070 10500 2578631 0 862131 0 27408070 25662604 19155 1256321 0 1257010 0 25681070 27700984 206117 -1732954 0 511543 0 25662604 24007033 107135 6885964 0 443804 2855344 27700984 0.0202 0.9341 0.0457 1 0 0 6188427 6188427 0 44437642 26747669 17689973 0 2025344 884818 1140526 0 7945312 6903795 1041517 0 0 0 0 26060443 0 0 Money Market 511828 F Fixed Income 7508048 F Domestic Equity 12433326 F International Equity 4778983 F Long/Short Positions 1625394 F Absolute Return 594936 F Real Estate 804321 F Alternative Investments 22345179 F Beneficial Interest in Trust 1127358 F 51729373 0 Agency Fund held for Womens Auxillary 32607 Refundable Advance-Grants 3724495 3757102 65210452 -275689 1449790 0 0 1174101 64036351 264041 -762515 -498474 63537877 66874052 1449790 0 0 0 1449790 65424262 264041 -762515 -498474 64925788 Schedule D, Part V, Line 4 Endowments are used to carry out the mission of the Organization, i.e. to conduct medical research related to women's health and to support the operation of Magee Womens Hospital of UPMC. Schedule D, Part X, Line 1 Advances received from Grantors of Grants and Awards are recognized as Refundable Advances-Grants, until conditions to revenue recognition are met. Such advances amounting to $ 3,724,495 are reported as Refundable Advances under Other Liabilities on Line 25 of the Balance Sheet (Part X). Schedule D, Part XI, Line 4b Fundraising expense $762,515 netted off against revenue in Part VIII Line 8(b) on Form 990. Schedule D, Part XII, Line 4b Fundraising expenses of $762,515 reported as expense in audited financial statements but reported as a revenue offset in Part VIII Line 8(b) of Form 990. 1 North America (including Canada and Mexico, but not the United States) 0 0 Grantmaking Bio-medical research 31204 East Asia and the Pacific 0 0 Grantmaking Bio-medical research 100769 Sub-Saharan Africa 0 0 Grantmaking Bio-medical research 3259679 0 0 3391652 East Asia and the Pacific Bio-medical Research 100769 Wire Transfer 0 N/A North America (including Canada and Mexico, but not the United States) Bio-medical Research 31204 Wire Transfer 0 N/A Sub-Saharan Africa Bio-medical Research 259060 Wire Transfer 0 N/A Sub-Saharan Africa Bio-medical Research 401789 Wire Transfer 0 N/A Sub-Saharan Africa Bio-medical Research 405553 Wire Transfer 0 N/A Sub-Saharan Africa Bio-medical Research 378789 Wire Transfer 0 N/A Sub-Saharan Africa Bio-medical Research 581221 Wire Transfer 0 N/A Sub-Saharan Africa Bio-medical Research 340282 Wire Transfer 0 N/A Sub-Saharan Africa Bio-medical Research 892985 Wire Transfer 0 N/A 9 0 0 0 0 0 0 0 Schedule F, Part I, Line 2 Schedule F, Part I, Line 2 - All grants and assistance to foreign organizations relate to collaborative bio-medical research with the Organization. Each arrangement is formalized with a contract which includes specific terms and conditions that must be met. Recipients are required to submit a detailed accounting of all expenditures incurred under the contract. This is reviewed for contract compliance and appropriateness and only then cash is remitted to them as reimbursement. Each recipient organization is also required to submit annual reports of all research activities funded by the grant, together with the results of the research. This information is reviewed by the US scientist leading the research. X X X X X X X 1 Pitch Consulting LLC 245 Tech Road Pittsburgh PA 15205 Manage and coordinate all aspects of identified fundraising events including marketing, researching & developing partnership leads and soliciting sponsorships. 0 606427 312500 293927 606427 312500 293927 AK AL AR CA CO CT DC DE FL GA HI IL KS KY MA MD MI MN MO MS MT NC ND NH NJ NM NY OH OK OR PA SC SD UT VA WA WI WV WY Women Who Rock Concert 420621 28272 392349 0 0 10000 0 25000 397294 Pars for Postpartum Depression 81078 9523 71555 0 0 26408 1063 0 19841 10 366510 190454 176056 0 0 59173 12490 0 185145 868209 228249 639960 0 0 95581 13553 25000 602280 736414 -96454 Schedule G, Part I, Line 2a Schedule G, Part I, Line 2b - The contract with Pitch Consulting LLC specifies that the consultant will be paid a monthly retainer. Activities for which Pitch Consulting was paid this retainer are summarized in responses to Schedule G Part I Line 2b I. Any expenses incurred by Pitch Consulting specific to fundraising events organized by them are invoiced for reimbursement to MWRIF along with supporting documentation. Schedule G, Part II, Line 11 Schedule G, Part II, Line 11 - Activity recorded here related to specific fundraising events reflects only those expenses and revenue recorded during the tax year ended June 30, 2025, based on GAAP accounting guidelines. In some cases, revenue and expenses related to these specific events may be recorded either prior or after this fiscal year depending on timing and the associated GAAP guidelines. As a result, the net income shown here does not reflect the final net income for all the listed events. In addition, any contributions received related to the listed events is disclosed as required in Part VIII of the 990 and has been excluded from the above recap of the events. 1 University of Wisconsin PO Box 78538 Milwaukee WI 53278 391805963 501(c)(3) 18844 Biomedical research Carnegie Mellon University 5000 Forbes Avenue WQED Building Pittsburgh PA 15213 250969449 501(c)(3) 97741 Biomedical research Sanford Burnham Prebys Medical Discovery Institute 10901 North Torrey Pines Road La Jolla CA 92037 510197108 501(c)(3) 7933 Biomedical research Pennsylvania State University 408 Old Main University Park PA 16802 246000376 501(c)(3) 22031 Biomedical research The RAND Corporation 1776 Main Street PO Box 2138 Santa Monica CA 90407 951958142 501(c)(3) 79398 Biomedical research Cleveland Clinic PO Box 931652 Cleveland OH 44193 340714585 501(c)(3) 44329 Biomedical research Medical University of South Carolina 179 Ashley Ave Charleston SC 29425 576000722 501(c)(3) 18859 Biomedical research Allegheny County Health Department 542 Fourth Avenue Pittsburgh PA 15219 251495653 501(c)(3) 50859 Biomedical research University of North Carolina at Chapel Hill PO Box 402420 Atlanta GA 30384 566001393 501(c)(3) 74242 Biomedical research The Methodist Hospital Research Institute 6565 Fannin Street Houston TX 77030 890721923 501(c)(3) 84228 Biomedical research University of Florida PO Box 113201 Suite 1250 East Campus Office Bldg Gainesville FL 32611 596002052 501(c)(3) 48218 Biomedical research Morehouse School of Medicine Inc 720 Westview Drive SW Atlanta GA 30310 581438873 501(c)(3) 26045 Biomedical research Trustees of Columbia University in the City of New York 615 West 131st Street 3rd Floor New York NY 10027 135598093 501(c)(3) 136475 Biomedical research OLD DOMINION UNIVERSITY RESEARCH FOUNDATION PO Box 6369 Norfolk VA 23508 546068198 501(c)(3) 1832428 Biomedical research Seattle Institute for Biomedical & Clinical Research 1660 S Columbian Way SIBCR 116 MIRECC Seattle WA 98108 911452438 501(c)(3) 78151 Biomedical research Regents of the University of Michigan 3003 S State St Ann Arbor MI 48109 386006309 501(c)(3) 70652 Biomedical research Three Rivers Mothers' Milk Bank 3127 Penn Ave Pittsburgh PA 15201 464221983 501(c)(3) 74530 Community engagement University of Utah 201 S Presidents Circle Room 411 Salt Lake City UT 84112 876000525 501(c)(3) 283334 Biomedical research University of Minnesota 450 McNamara Alumni Center 200 Oak Street SE Minneapolis MN 55455 416007513 115 61403 Biomedical research Maya Organization 7451 Washington Avenue Swissvale PA 15218 264405956 501(c)(3) 13192 Biomedical research Pittsburgh Public Schools 341 S Bellefield Avenue Pittsburgh PA 15213 161678379 501(c)(3) 21346 Community engagement PPD Development LP 300 Industy Drive Pittsburgh PA 15275 742325267 C Corp 130147 Biomedical research University of Texas Southwestern Medical Center 5323 Harry Hines Blvd MC9029 Dallas TX 75390 726002868 501(c)(3) 24548 Biomedical research University of Maryland Baltimore 620 Lexington Street 4th floor Baltimore MD 21201 526002033 501(c)(3) 50852 Biomedical research Ohio State University 154 WEST 12TH AVE Columbus OH 43210 316025986 115 68274 Biomedical research Oregon Health & Science University 3181 SW Sam Jackson Park Rd L106OPAM Portland OR 97239 931176109 115 412402 Biomedical research Research Fdn for the State University of New York 211 UB Commons 520 Lee Entrance Amherst NY 14228 141368361 501(c)(3) 410046 Biomedical research Johns Hopkins University 3910 Keswick Road N4327-B Baltimore MD 21211 520595110 501(c)(3) 242844 Biomedical research The Children's Hospital of Philadelphia 3615 Civic Center Blvd Abramson Research Center 1215A Philadelphia PA 19104 231352166 501(c)(3) 186086 Biomedical research The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd Houston TX 77030 746001118 501(c)(3) 458525 Biomedical research Cornell University 341 Pine Tree Road Ithaca NY 14850 150532082 501(c)(3) 282877 Biomedical research International AIDS Vaccine Initiative 125 Broad Street 9th Floor New York NY 10004 133870223 501(c) 444648 Biomedical research University of California San Diego 9500 Gilman Avenue La Jolla CA 92093 956006144 501(c)(3) 118490 Biomedical research Public Health Institute 555 12th St Suite 600 Oakland CA 94607 941646278 501(c)(3) 428456 Biomedical research Healthy Start Inc 400 N Lexington Avenue Pittsburgh PA 15208 251691864 501(c)(3) 485689 Participant recruiting for research study Duke University 2200 W Main Street Ste 710 Durham NC 27705 560532129 501(c)(3) 138429 Biomedical research University of Colorado Denver 13001 E 17th Place Room W1124 Bldg 500 Grants and Contracts Aurora CO 80045 846000555 501(c)(3) 144789 Biomedical research University of Washington 4333 Brooklyn Ave NE Seattle WA 98195 916001537 115 674853 Biomedical research Family Health International 359 Blackwell Street Suite 200 Durham NC 27701 237413005 501(c)(3) 880325 Biomedical research PATH 2201 Westlake Avenue Suite 200 Seattle WA 98121 911157127 501(c)(3) 482059 Biomedical research Research Triangle Institute 3040 Cornwallis Road Research Triangle Park NC 27709 560686338 501(c)(3) 441394 Biomedical research Fred Hutchinson Cancer Research Center 1100 Fairview Ave N MS-J6-500 Seattle WA 98109 237156071 501(c)(3) 61009 Biomedical research The Population Council Inc One Dag Hammarskjold Plaza New York NY 10017 131687001 501(c)(3) 503723 Biomedical research Magee Womens Hospital of UPMC 300 Halket St Pittsburgh PA 15213 250965420 501(c)(3) 2495197 Program Support Eastern Virginia Medical School 358 Mowbray Arch PO Box 1980 Norfolk VA 23501 546055378 501(c)(3) 1433723 Biomedical research Oak Crest Institute of Science 132 W Chestnut Avenue Monroiva CA 91016 954680961 501(c)(3) 3165378 Biomedical research University of Pittsburgh 4200 Fifth Avenue Pittsburgh PA 15260 250965591 501(c)(3) 9490449 Biomedical research Trustees of Boston College 104 Commonwealth Avenue 129 Lake - Room 440 Chestnut Hill MA 02467 042103545 501(c)(3) 108699 Bio-medical Research Dartmouth-Hitchcock Clinic One Medical Center Drive Lebanon NH 03756 222519596 501(c)(3) 35930 0 Bio-medical Research Ponce Medical School Foundation Inc PO Box 7004 Ponce PR 00732 660379122 501(c)(3) 9619 0 Bio-medical Research 47 3 Schedule I, Part I, Line 2 Schedule I, Part 1, Line 2. Each recipient of grant funding enters into a contract with MWRIF. The contract details allowable use of funds and includes budget expenditures. Funds are released to recipients on a cost reimbursement basis. The recipient submits a report summarizing the expenses incurred which is compared by MWRIF personnel against budgets and terms of the contract before funds are released. X 1 1 X X X 0 0 0 0 0 0 0 1 0 Michael Annichine CEO 396510 0 180000 0 13569 0 38908 0 22197 0 651184 0 10342 0 Pamela Moalli Interim Executive Director/Professor 236976 0 0 0 0 0 24000 0 22979 0 283955 0 0 0 Yoel Sadovsky Principal Investigator 376125 0 151327 0 24778 0 62431 0 22823 0 637484 0 0 0 Gerald Schatten Principal Investigator 367255 0 37184 0 0 0 41400 0 20397 0 466236 0 0 0 Sharon Hillier Principal Investigator 309392 0 60000 0 0 0 37301 0 8556 0 415249 0 0 0 Kyle Orwig Principal Investigator 307807 0 33183 0 0 0 37364 0 10665 0 389019 0 0 0 Lisa Rohan Principal Investigator 219250 0 62500 0 0 0 30005 0 24687 0 336442 0 0 0 Schedule J, Part I, Line 1a Membership dues for The Duquesne Club, a private club located in Pittsburgh Downtown Business district, were paid by MWRIF for Michael Annichine, CEO for part of the year. The Club's facility was used to host Board and Donor meetings and related events. Schedule J, Part I, Line 3 The (Interim) Executive Director of MWRIF is dually employed by both the University of Pittsburgh and the University of Pittsburgh Medical Center (UPMC). The Executive Director's time is spent on medical research, their executive director's responsibilities, and their clinical responsibilities to take care of patients. MWRIF is financially responsible for the Executive Director's compensation related to medical research and their executive director's responsibilities; it reimburses the University of Pittsburgh and UPMC for this compensation. Each of the three organizations are involved in evaluating the Executive Director's compensation taking into consideration their accomplishments, responsibilities, and comparing against AAMC (American Association of Medical Colleges) benchmarks. The initial salary as well as any subsequent adjustments are approved by senior management of the University of Pittsburgh and UPMC and by selected external members of the MWRIF Board. All paperwork regarding the process and approvals is maintained by the respective organizations. The CEO's initial salary as well as subsequent adjustments are reviewed by UPMC and select independent directors of the MWRIF Board, taking into consideration qualifications, responsibilities, accomplishments, and a review of salaries for comparable positions in the marketplace. All related paperwork is maintained by UPMC. Since 100% of the CEO's time is spent supporting the mission of MWRIF, MWRIF is responsible for the entire salary and any subsequent adjustments and incentives. Schedule J, Part I, Line 7 Pamela Moalli, Yoel Sadovsky, Gerald Schatten, Sharon Hillier, Kyle Orwig, and Lisa Rohan are eligible to earn research incentive based on certain criteria established by the University of Pittsburgh for all researchers. The CEO, as an executive-level employee of UPMC, is eligible for an annual incentive award based on performance against predetermined standards which include their contribution to achievement of corporate goals, as well as achievement of individual performance goals. MWRIF is financially responsible for the entire cost of the incentives. X 6 46384 Quoted market price X Gift vouchers, sports memorablia, musical instruments, and food items 87 33723 Fair market value 0 1 1 Schedule M, Part I, Line 32b MWRIF uses the services of J.P.Morgan Chase to receive securities from donors and to sell them in the market. Fundraising consultant Pitch Consulting LLC helps raise in-kind contributions for fundraising events. Form 990, Part I, Line 5 (and Part V, Line 2a) - MWRIF doesn't have any employees of its own. All individuals who work in support of the mission of MWRIF are employed either by the University of Pittsburgh or the University of Pittsburgh Medical Center (UPMC). MWRIF is billed by each organization for the cost of salary and fringe benefits corresponding to the effort these individuals expend in support of the MWRIF mission. MWRIF records such costs as compensation on its financial statements. Payroll taxes are filed by the employer organizations. Form 990, Part III, Line 1 Magee-Womens Research Institute (MWRI) is one of the largest research institutes worldwide devoted exclusively to women's health research. Our mission is to advance scientific knowledge in the field of reproductive sciences and women's health; to accelerate the translation of that research into practice and improved clinical outcomes; to train the next generation of scientists in the field; to change the world's thinking on women's health and its investment in women's health research; and to expand our worldwide collaborative research. We focus on seven areas of research, including reproductive endocrinology and infertility; reproductive development; pregnancy and newborn medicine; gynecology; infectious diseases; women's cancers and women's wellness and health services. Form 990, Part III, Line 4a Magee-Womens Research Institute (MWRI) is one of the largest research institutes worldwide devoted exclusively to reproductive sciences and women's health research. MWRI is making discoveries and advancing knowledge in many areas affecting women including: reproductive biology and development, female cancer genomics and personalized therapies, HIV immunization and prevention, fertility preservation, and pelvic floor research. Through our revolutionary 9-90TM research, we focus on how pregnancy and fetal development can affect health and disease prevention for future generations. We firmly believe that new insights into the role of early human development in defining short- and long-term health and wellness will transform our understanding of disease development, treatment and prevention for future generations. Researchers concentrate on seven key areas of discovery: reproductive endocrinology and infertility (including ovarian biology, female and male germ cell development, infertility and restoration of fertility); reproductive development (including reproductive development, stem cell biology, germ cell development and differentiation and microbiome and development); pregnancy and newborn medicine (including prenatal genetics, feto-placental development, preterm birth, preeclampsia, newborn medicine); gynecology (including family planning, benign gynecological disorders, urogynecology and pelvic floor dysfunction); infectious diseases (including HIV and vaginal microbicides, reproductive tract infections, pharmaceutics and drug delivery); women's cancers (reproductive tract cancers); and women's wellness and health services outcomes (including patient-provider communication, substance use disorders, behavioral health and alternative medicine). Considering our depth and breadth, MWRI strives to advance scientific discovery and translate the results of scientific research into knowledge pertinent to women's health. To ensure the future of women's health research, MWRI has established educational programs at all levels of academic development, including opportunities for faculty and postdoctoral scholars as well as graduate and medical students, college students and high school students. MWRI hosts the Magee-Womens Research Summit, an international conference of physicians, researchers and corporate leaders focused on women's health. The centerpiece of the summit is the award of a $1 million prize for collaborative and transformative research within the reproductive sciences. Dedicated to solving real-world problems and improving lives today and for future generations as well as to coaching the next generation of scientists, MWRI is committed to a better, healthier world in which women's health has the scientific prominence and cultural status it deserves. Form 990, Part VI, Section B, Line 11b The initial draft of Form 990, which is prepared by the MWRIF Project Manager-Finance, is reviewed by the Sr. Director of Finance. It is then reviewed by a representative of MWRIF's external auditors Maher Duessel. After that, the Audit Committee, a sub-committee of the Board of Directors, reviews and provides a report to the Board. A copy of the Form 990 is provided to the full Board of Directors prior to filing with the IRS. Form 990, Part VI, Section B, Line 12c The organization has a conflict of interest policy that is driven by the classification of each individual as follows: Board members are required to sign a formal conflict of interest questionnaire annually prior to the beginning of each fiscal year for which they are a member. The forms are reviewed internally by the CEO and actual or potential conflicts are reported to the Board Chair. * Designated individuals (managers and above, and any employee holding a position of influence or trust) supporting MWRIF who are employed by UPMC are required to follow their employer mandated conflict of interest policy which includes annual electronic disclosures, as well as additional disclosures as related circumstances change. These are reviewed and monitored by the UPMC Ethics and Compliance Committee. If potential and actual conflicts are identified, a Conflict Management Plan must be developed and submitted to the Committee. Failure to disclose potential conflicts or to follow the approved conflict management plan will result in disciplinary action. * Designated individuals (all faculty, staff with administrator IV title or above and any others designated based on their responsibilities) working at MWRIF who are employees of the University of Pittsburgh are required to follow their employer mandated conflict of interest policy which includes annual electronic conflict of interest disclosures, as well as additional disclosures as related circumstances change. These are reviewed by the individual's department head and reported to University senior management as well as maintained by the Conflict of Interest Committee. Potential or actual conflicts are handled by the employees first line supervisor and a management plan developed. The plan is submitted to senior management as well as the COI committee for review. Sanctions may be applied for non-compliance with the requirements of the policy or with management plans, including a letter of reprimand, special monitoring of future work, removal from the particular project, probation, suspension, salary reduction, or initiation of steps leading to possible reduction in rank or termination of employment. Form 990, Part VI, Section B, Line 15 The (Interim) Executive Director of MWRIF is dually employed by both the University of Pittsburgh and the University of Pittsburgh Medical Center (UPMC). The (Interim) Executive Director's time is spent on medical research, their Executive Director's responsibilities, and their clinical responsibilities to take care of patients. MWRIF is financially responsible for the (Interim) Executive Director's compensation related to medical research and their Executive Director's responsibilities; MWRIF reimburses the University of Pittsburgh and UPMC for this compensation. Each of the three organizations are involved in evaluating the Executive Director's compensation taking into consideration their accomplishments, responsibilities, and comparing against AAMC (American Association of Medical Colleges) benchmarks. The initial salary as well as any subsequent adjustments are approved by senior management of the University of Pittsburgh and UPMC and by selected external members of the MWRIF Board. All paperwork regarding the process and approvals is maintained by the respective organizations. The CEO's initial salary as well as any subsequent adjustments are reviewed by both UPMC and select independent directors of the MWRIF Board, taking into consideration accomplishments, responsibilities and a review of salaries for comparable positions in the marketplace. All related paperwork is maintained by UPMC. Since 100% of the CEO's time is spent in supporting the mission of MWRIF, MWRIF is financially responsible for the entire salary and any subsequent adjustments and incentives. Form 990, Part VI, Section C, Line 17 AK, AL, AR, CA, CO, CT, DC, FL, GA, HI, IL, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NH, NJ, NM, NY, OH, OK, OR, PA, SC, TN, UT, VA, WA, WI, WV Form 990, Part VI, Section C, Line 19 The Conflict of Interest Policy, governing documents, and financial statements are available at the Organization's business office located at 204 Craft Ave, Pittsburgh, PA 15213. Form 990, Part VII, Section A, Line 1a Dr. Yoel Sadovsky stepped down from his position as Executive Director of MWRIF effective June 30, 2024. He remained employed as Principal Investigator until June 30, 2025. Dr. Pamela Moalli became Interim Executive Director effective July 1st, 2024. Form 990, Part VIII, Line 6a The research conducted at MWRIF occurs in a facility located at 204 Craft Avenue. UPMC owns this building, and MWRIF is renting the space from them. Since the lease agreement with UPMC is long term (30 years), for accounting purposes it has to be recorded as a liability on MWRIF's books. This is the mortgage/note payable disclosed on Line 24 of Part X. The lease agreement does not contain any terms implying that MWRIF will ever own or have the option to buy the building. The rental income disclosed in Part VIII is generated by subleases between MWRIF and several research labs that are part of the University of Pittsburgh, allowing them to occupy a portion of the space MWRIF is renting from UPMC. These particular University of Pittsburgh researchers collaborate with MWRIF researchers on a regular basis on large biomedical research projects where physical proximity facilitates the collaborative process and allows them to meet, share equipment and other resources as needed to make the collaboration more efficient and hopefully more successful. The objective in renting the space to the University of Pittsburgh is to facilitate the collaboration, not to generate profit. So, the rental income disclosed in Part VIII is sublease income that offsets a portion of MWRIF's lease expense. MWRIF has no acquisition indebtedness which would require the rental income to be disclosed as unrelated business income.